Result of AGM
20th May 2020
Cello Health plc (AIM: CLL), the global healthcare-focused advisory group, held its Annual General Meeting (“AGM”) earlier today at which all resolutions were duly passed.
The votes were as follows:
1. Approve the Report & Accounts
2. Approve the Remuneration Report
3. Re-elect Chris Jones
4. Re-elect Mark Bentley
5. Re-elect Stephen Highley
6. Re-appoint auditors
7. Section 551 authority
8. Section 570 authority
9. Section 701 authority
* Please note that a vote withheld is not a vote in law.
020 7812 8460
Mark Scott, Chief Executive
Mark Bentley, Group Finance Director
020 7397 8900
020 7466 5000
Notes to Editors
Cello Health plc is a global healthcare-focused advisory Group comprised of a set of leading scientific, commercial advisory and digital delivery capabilities. Cello Health plc currently services 24 of the top 25 pharmaceutical clients globally, as well as a wide range of biotech, diagnostics, devices and other key non-healthcare clients.
Cello Health plc enables clients to commercialise, differentiate their assets, and drive brand success in ever more complex global markets. The business delivers its services through nearly 1,000 highly skilled professionals, utilising latest thinking, technology and digital solutions.
Cello Health plc delivers its services from an office network in the UK, USA, and Asia, with hub offices in New York City, Philadelphia, New Jersey, London, Edinburgh, and Farnham.
For further information, please visit: https://cellohealthplc.com